Top Markets
Coin of the day
Hunan Er-Kang Pharmaceutical Co., Ltd Hunan Er-Kang Pharmaceutical Co., Ltd

Hunan Er-Kang Pharmaceutical Co., Ltd

300267
Rangering i aksjer #9472
Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that... Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs), completed drug formulations, and pharmaceutical excipients, serving both the Chinese domestic market and international clients. Its API portfolio features substances such as glycerin, dilute hydrochloric acid, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's principal finished medications include sulbenicillin sodium for injection and compound liquorice tablets. For conventional pharmaceutical excipients, it provides items like pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose. Furthermore, its advanced pharmaceutical excipient offerings encompass hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate along with its related product series. The firm was established in 2003 and is headquartered in Liuyang, China.
Aksjekurs
$0.48835979
Sist synkronisert: 2026-08-28
Markedsverdi
$1.01B
Endring (1 dag)
-1.46%
Endring (1 år)
-9.78%
Land
CN
Handel Hunan Er-Kang Pharmaceutical Co., Ltd (300267)

Kategori

Inntekter for Hunan Er-Kang Pharmaceutical Co., Ltd (300267)
Inntekter i 2026 TTM: 0
Ifølge Hunan Er-Kang Pharmaceutical Co., Ltd sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Hunan Er-Kang Pharmaceutical Co., Ltd fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter